Koninklijke Philips Long-Term Investments 2010-2024 | PHG

Koninklijke Philips long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Koninklijke Philips long-term investments for the quarter ending September 30, 2024 were $0.311B, a 30.19% decline year-over-year.
  • Koninklijke Philips long-term investments for 2023 were $0.412B, a 27.66% decline from 2022.
  • Koninklijke Philips long-term investments for 2022 were $0.57B, a 12.57% increase from 2021.
  • Koninklijke Philips long-term investments for 2021 were $0.506B, a 84.7% increase from 2020.
Koninklijke Philips Annual Long-Term Investments
(Millions of US $)
2023 $412
2022 $570
2021 $506
2020 $274
2019 $262
2018 $289
2017 $185
2016 $276
2015 $265
2014 $209
2013 $214
2012 $228
2011 $283
2010 $240
2009 $392
Koninklijke Philips Quarterly Long-Term Investments
(Millions of US $)
2024-06-30 $311
2023-06-30 $508
2023-03-31
2022-06-30 $679
2021-06-30 $446
2020-06-30 $248
2019-06-30 $283
2018-06-30 $327
2017-06-30 $195
2016-12-31 $276
2016-09-30 $267
2016-06-30 $299
2016-03-31 $276
2015-12-31 $265
2015-09-30 $254
2015-06-30 $248
2015-03-31 $266
2014-12-31 $209
2014-09-30 $210
2014-06-30 $235
2014-03-31 $249
2013-12-31 $214
2013-09-30 $219
2013-06-30 $214
2013-03-31 $232
2012-12-31 $228
2012-09-30 $244
2012-06-30 $261
2012-03-31 $261
2011-12-31 $283
2011-09-30 $279
2011-06-30 $236
2011-03-31 $232
2010-12-31 $240
2010-09-30 $234
2010-06-30 $244
2010-03-31 $229
2009-12-31 $392
2009-09-30 $386
2009-06-30 $334
2009-03-31 $313
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.454B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.059B 26.03
Stryker (SYK) United States $139.868B 31.52
Boston Scientific (BSX) United States $124.863B 35.90
Medtronic (MDT) Ireland $114.537B 17.04
EssilorLuxottica (ESLOY) France $110.799B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.365B 0.00
Haleon (HLN) United Kingdom $44.180B 28.71
GE HealthCare Technologies (GEHC) United States $39.743B 20.61
ResMed (RMD) United States $35.761B 29.39
Terumo (TRUMY) Japan $28.532B 40.29
Zimmer Biomet Holdings (ZBH) United States $21.582B 13.74
Baxter (BAX) United States $18.264B 12.39
Insulet (PODD) United States $16.648B 70.04
Smith & Nephew SNATS (SNN) United Kingdom $11.052B 0.00
Bio-Rad Laboratories (BIO) United States $10.282B 35.10
BellRing Brands (BRBR) United States $8.726B 36.90
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $8.016B 19.24
ICU Medical (ICUI) United States $4.201B 40.09
TG Therapeutics (TGTX) United States $3.771B 0.00
Haemonetics (HAE) United States $3.763B 18.61
Envista Holdings (NVST) United States $3.662B 27.28
Prestige Consumer Healthcare (PBH) United States $3.657B 18.22
Perrigo (PRGO) Ireland $3.466B 10.95
Neogen (NEOG) United States $3.127B 36.08
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.988B 18.00
QuidelOrtho (QDEL) United States $2.628B 16.56
Agios Pharmaceuticals (AGIO) United States $2.557B 0.00
Green Thumb Industries (GTBIF) United States $2.260B 38.14
LeMaitre Vascular (LMAT) United States $2.165B 52.65
Curaleaf Holdings (CURLF) Canada $2.023B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.960B 0.00
Warby Parker (WRBY) United States $1.769B 0.00
AtriCure (ATRC) United States $1.641B 0.00
InMode (INMD) Israel $1.460B 8.78
AdaptHealth (AHCO) United States $1.365B 9.85
Verano Holdings (VRNOF) United States $1.231B 0.00
BioLife Solutions (BLFS) United States $1.179B 0.00
Evolus (EOLS) United States $1.036B 0.00
Owens & Minor (OMI) United States $0.925B 7.23
National Vision Holdings (EYE) United States $0.915B 29.08
Phibro Animal Health (PAHC) United States $0.906B 18.80
CeriBell (CBLL) United States $0.893B 0.00
Capricor Therapeutics (CAPR) United States $0.844B 0.00
Cresco Labs (CRLBF) United States $0.747B 0.00
VAREX IMAGING (VREX) United States $0.542B 16.36
Surmodics (SRDX) United States $0.536B 113.85
Quanterix (QTRX) United States $0.532B 0.00
Canopy Growth (CGC) Canada $0.515B 0.00
Valneva SE (VALN) France $0.475B 0.00
ZimVie (ZIMV) United States $0.398B 33.56
Viemed Healthcare (VMD) United States $0.331B 35.54
Aurora Cannabis (ACB) Canada $0.328B 0.00
OraSure Technologies (OSUR) United States $0.315B 8.12
TerrAscend (TSNDF) Canada $0.309B 0.00
Jin Medical (ZJYL) China $0.308B 0.00
Sanara MedTech (SMTI) United States $0.293B 0.00
Cerus (CERS) United States $0.290B 0.00
Biote (BTMD) United States $0.280B 12.93
Ayr Wellness (AYRWF) United States $0.279B 0.00
Zynex (ZYXI) United States $0.255B 53.33
Omeros (OMER) United States $0.246B 0.00
High Tide (HITI) Canada $0.234B 97.00
MacroGenics (MGNX) United States $0.232B 0.00
Utah Medical Products (UTMD) United States $0.225B 15.14
Organigram Holdings (OGI) Canada $0.195B 0.00
Brainsway (BWAY) Israel $0.172B 206.40
FitLife Brands (FTLF) United States $0.145B 19.54
Rockwell Medical (RMTI) United States $0.121B 0.00
TriSalus Life Sciences (TLSI) United States $0.117B 0.00
Quipt Home Medical (QIPT) United States $0.113B 0.00
Veru (VERU) United States $0.107B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 23.90
Fonar (FONR) United States $0.092B 9.51
Jushi Holdings (JUSHF) United States $0.092B 0.00
Cellectar Biosciences (CLRB) United States $0.082B 0.00
Zevia PBC (ZVIA) United States $0.079B 0.00
InterCure (INCR) Israel $0.079B 0.00
Modular Medical (MODD) United States $0.073B 0.00
Safety Shot (SHOT) United States $0.065B 0.00
Sanuwave Health (SNWVD) United States $0.064B 1.63
MariMed (MRMD) United States $0.062B 0.00
Cytosorbents (CTSO) United States $0.047B 0.00
Allurion Technologies (ALUR) United States $0.045B 0.00
Exagen (XGN) United States $0.043B 0.00
Apyx Medical (APYX) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Nephros (NEPH) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
GlucoTrack (GCTK) United States $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 17.87
SNDL (SNDL) Canada $0.000B 0.00